Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

× No keyword cloud information.

616 in total

1. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.

Authors: Hiroyuki Nishi; Taichi Sakaguchi; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa
Journal: Heart Vessels Date: 2012-06-03 Impact factor: 2.037

2. [Epidemiology, clinical picture and management of atrial fibrillation].

Authors: J Röther
Journal: Nervenarzt Date: 2011-02 Impact factor: 1.214

Review 3. Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.

Authors: Sean T Duggan; Lesley J Scott
Journal: Drugs Date: 2011-01-22 Impact factor: 9.546

Review 4. Atrial fibrillation (chronic).

Authors: Deirdre A Lane; Stavros Apostolakis; Christopher J Boos; Gregory Y H Lip
Journal: BMJ Clin Evid Date: 2011-11-10

5. Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.

Authors: Daniela Poli; Sophie Testa; Emilia Antonucci; Elisa Grifoni; Oriana Paoletti; Gregory Y H Lip
Journal: Chest Date: 2011-04-21 Impact factor: 9.410

6. Point-by-point pulmonary vein antrum isolation guided by intracardiac echocardiography and 3D mapping and duty-cycled multipolar AF ablation: effect of multipolar ablation on procedure duration and fluoroscopy time.

Authors: Yaariv Khaykin; Lauren Zarnett; Daniel Friedlander; Zaev A Wulffhart; Bonnie Whaley; David Giewercer; Bernice Tsang; Atul Verma
Journal: J Interv Card Electrophysiol Date: 2012-03-11 Impact factor: 1.900

7. Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Authors: J L M Hendriks; R Nieuwlaat; H J M Vrijhoef; R de Wit; H J G M Crijns; R G Tieleman
Journal: Neth Heart J Date: 2010-10 Impact factor: 2.380

8. Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.

Authors: Rohit Malhotra; Kenneth C Bilchick; John P DiMarco
Journal: Am J Cardiol Date: 2013-11-09 Impact factor: 2.778

9. The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.

Authors: Ming-Liang Zuo; Shasha Liu; Koon-Ho Chan; Kui-Kai Lau; Boon-Hor Chong; Kwok-Fai Lam; Yap-Hang Chan; Yuk-Fai Lau; Gregory Y H Lip; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal: J Interv Card Electrophysiol Date: 2013-02-07 Impact factor: 1.900

10. Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors: Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal: Clin Drug Investig Date: 2015-11 Impact factor: 2.859